Power calculation for the general two-sample Mendelian randomization analysis

被引:24
|
作者
Deng, Lu [1 ]
Zhang, Han [1 ]
Yu, Kai [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA
关键词
genome-wide association studies; Mendelian randomization; power calculation; two-stage least squares estimator; BODY-MASS INDEX; SAMPLE-SIZE; ASSOCIATION; INSTRUMENTS; STATISTICS; TRAITS; DESIGN; GWAS; BIAS;
D O I
10.1002/gepi.22284
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mendelian randomization (MR) study has become a powerful approach to assess the potential causal effect of a risk exposure on an outcome. Most current MR studies are conducted under the two-sample setting by combining summary data from two separate genome-wide association studies (GWAS), with one providing measures on associations between genetic markers and the risk exposure, and the other on associations between genetic markers and the outcome. We develop a power calculation procedure for the general two-sample MR study, allowing for the use of multiple genetic markers, and shared participants between the two GWAS. This procedure requires a few easy-to-interpret parameters and is validated through extensive simulation studies.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 50 条
  • [31] Narcolepsy and cardiovascular disease: A two-sample Mendelian randomization study
    Tao, Yanmin
    Luo, Jingsong
    Xu, Yaxin
    Wang, Hongyan
    Tian, Jing
    Yang, Shenbi
    Yu, Kexin
    Peng, Sihan
    Zhang, Xiangeng
    SLEEP MEDICINE, 2024, 113 : 6 - 12
  • [32] Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study
    Kjaergaard, Alisa D.
    Teumer, Alexander
    Witte, Daniel R.
    Stanzick, Kira-Julia
    Winkler, Thomas W.
    Burgess, Stephen
    Ellervik, Christina
    CLINICAL CHEMISTRY, 2022, 68 (03) : 461 - 472
  • [33] Thyroid dysfunction and sarcopenia: a two-sample Mendelian randomization study
    Wei, Jiaxin
    Hou, Shuanglong
    Hei, Peng
    Wang, Gang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [34] HIV and risk of hypertension: a two-sample Mendelian randomization study
    Zhu, Ruo-Wei
    Guo, Hui-Yi
    Niu, Lu-Na
    Deng, Mi
    Li, Xue-Fei
    Jing, Lu
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [35] Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study
    Ma, Xiao-Na
    Feng, Wei
    Chen, Shu-Lin
    Zhong, Xiao-Qin
    Lin, Chang-Song
    Xu, Qiang
    NEUROLOGY AND THERAPY, 2024, 13 (03) : 715 - 725
  • [36] A two-sample Mendelian randomization study of lipidome and lung cancer
    Fan, Zhang
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2025, 252
  • [37] Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
    Jiang, Miaomiao
    Yan, Weiheng
    Zhang, Yuyanan
    Lu, Zhe
    Lu, Tianlan
    Zhang, Dai
    Li, Jun
    Wang, Lifang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [38] Telomere Length and Hearing Loss: A Two-Sample Mendelian Randomization
    Liu, Yun
    Liu, Shuangyan
    Xin, Jiarui
    Qian, Peiyi
    Guo, Shuli
    Xu, Xiaojun
    Wang, Dahui
    Yang, Lei
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (15)
  • [39] A Two-Sample Mendelian Randomization Study of Neuroticism and Sleep Bruxism
    Strausz, T.
    Strausz, S.
    Jones, S. E.
    Palotie, T.
    Lobbezoo, F.
    Ahlberg, J.
    Ollila, H. M.
    JOURNAL OF DENTAL RESEARCH, 2024, 103 (10) : 980 - 987
  • [40] Hypothyroidism and rheumatoid arthritis: a two-sample Mendelian randomization study
    Gao, Yang
    Fan, Zheng-Rui
    Shi, Fang-Yuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14